| Announce Date | 01/13/2026 |
| EPS Normalized Actual | $2.95 (Beat by $0.02) |
| EPS GAAP Actual | $2.95 (Beat by $0.02) |
| Revenue Actual | $2.55292B |
| Revenue Surprise | Beat by $2552.92M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Nov 2029 | 15.18869 | 2.63 | 15.08996 | 15.30442 | 1 |
| Nov 2029 | 15.18869 | 2.63 | 15.091 | 15.34673 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | -23.85 | -23.85 | 2.55292B | 4.11% | 2552.92M |
| FQ3 2025 (Aug 2025) | 1.34 | 1.34 | 2.48325B | 3.86% | 2483.25M |
| FQ2 2025 (May 2025) | 0.63 | 0.63 | 2.41737B | 1.52% | 2417.37M |
| FQ1 2025 (Feb 2025) | 1.04 | 1.04 | 2.37222B | -1.29% | 2372.22M |
| FQ4 2024 (Nov 2024) | 1.8 | 1.8 | 2.44802B | 8.87% | 2448.02M |
| FQ3 2024 (Aug 2024) | 0.26 | 0.26 | 2.38741B | 100% | 2387.41M |
| FQ1 2019 (Feb 2019) | 0 | 0 | 1.17327B | 100% | 1173.27M |
| FQ2 2019 (May 2019) | 0 | 0 | 1.16088B | 100% | 1160.88M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2029 (Aug 2029) | 3.83575 | -- | 3.81653 | 3.86786 | 1 |
| FQ2 2029 (May 2029) | 3.54689 | -- | 3.52912 | 3.57658 | 1 |
| FQ1 2029 (Feb 2029) | 3.72322 | -- | 3.69882 | 3.74961 | 1 |
| FQ3 2028 (Aug 2028) | 3.56073 | -- | 3.54289 | 3.59054 | 2 |
| FQ2 2028 (May 2028) | 3.27722 | -- | 3.2608 | 3.30465 | 2 |
| FQ1 2028 (Feb 2028) | 3.44859 | -- | 3.42599 | 3.47303 | 1 |
| FQ4 2027 (Nov 2027) | 3.3047 | -- | 3.28945 | 3.31982 | 1 |
| FQ3 2027 (Aug 2027) | 3.3209 | -- | 3.30557 | 3.33609 | 1 |
| FQ2 2027 (May 2027) | 3.205 | -- | 3.18894 | 3.23183 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2029 (Aug 2029) | 2.7B | -- | 2.69B | 2.72B | 1 |
| FQ2 2029 (May 2029) | 2.69B | -- | 2.68B | 2.71B | 1 |
| FQ1 2029 (Feb 2029) | 2.7B | -- | 2.69B | 2.72B | 1 |
| FQ3 2028 (Aug 2028) | 2.63B | -- | 2.62B | 2.65B | 1 |
| FQ2 2028 (May 2028) | 2.63B | -- | 2.62B | 2.64B | 1 |
| FQ1 2028 (Feb 2028) | 2.63B | -- | 2.62B | 2.65B | 1 |
| FQ4 2027 (Nov 2027) | 2.56B | -- | 2.55B | 2.57B | 2 |
| FQ3 2027 (Aug 2027) | 2.49B | -- | 2.48B | 2.5B | 2 |
| FQ2 2027 (May 2027) | 2.55B | -- | 2.54B | 2.57B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | -23.85 | -23.85 | 100% | |
| FQ3 2025 (Aug 2025) | 1.34 | 1.34 | 100% | |
| FQ2 2025 (May 2025) | 0.63 | 0.63 | 100% | |
| FQ1 2025 (Feb 2025) | 1.04 | 1.04 | 100% | |
| FQ4 2024 (Nov 2024) | 1.8 | 1.8 | 100% | |
| FQ3 2024 (Aug 2024) | 0.26 | 0.26 | 100% | |
| FQ1 2019 (Feb 2019) | 0 | 0 | NAN% | |
| FQ2 2019 (May 2019) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $2.55B | $2552.92M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $2.48B | $2483.25M | 100% |
| FQ2 2025 (May 2025) | $0B | $2.42B | $2417.37M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $2.37B | $2372.22M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $2.45B | $2448.02M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $2.39B | $2387.41M | 100% |
| FQ1 2019 (Feb 2019) | $0B | $1.17B | $1173.27M | 100% |
| FQ2 2019 (May 2019) | $0B | $1.16B | $1160.88M | 100% |